Persistent Asset Partners Ltd

SEC CIK: 0002056052
Latest filing: Aug 6, 2026

SEC filings (opens in a new tab)

SYRE holding history

Spyre Therapeutics, Inc. in every 13F filed by Persistent Asset Partners Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SYRE overview All 13F holders of SYRE Full Q2 2026 holdings

Shares (Q2 2026): 8,760
Value: $777.7K
% of portfolio: 0.2%
Quarters held: 3; Since Q4 2025

Holdings of SYRE by Persistent Asset Partners Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	8,760	$777.7K	0.2%	+3,957+82.4%	Added	Holders
Q1 2026	4,803	$242.3K	0.1%	+2,557+113.8%	Added	Holders
Q4 2025	2,246	$73.6K	<0.1%	+2,246	New	Holders